Structure Therapeutics (GPCR) AGM 2026 summary

Opening remarks and agenda

• Meeting commenced at 9:00 A.M. Pacific Time on June 17th, 2026, with board members and key executives introduced.

• Attendees included the board, executive team, independent auditors, and legal counsel.

Shareholder proposals

• Three proposals presented: election of Class III Directors, ratification of Ernst & Young LLP as auditors for 2026, and advisory approval of executive compensation.

• Voting was conducted online, with polls closed after proposal presentation.

• No questions were submitted regarding the proposals.

Overview of voting outcomes

• Quorum was established with over one-third of shares represented.

• All three proposals received the necessary votes to pass; final results to be filed on Form 8-K.